Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$220,695
-$255,745 QoQ
Shares Held
184
-64.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#4,370
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Willis Johnson & Associates, Inc. holds $220,695 across 1 Drug Manufacturers - General name. LLY ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
184 | $220,695 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,695 | 184 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $476,440 | 518 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $554,534 | 516 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $308,252 | 404 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $294,662 | 378 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $347,708 | 421 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $285,640 | 370 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $630,789 | 712 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $587,591 | 649 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $413,096 | 531 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $229,087 | 393 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||